首页|Type Ⅰ interferon signaling facilitates resolution of acute liver injury by priming macrophage polarization

Type Ⅰ interferon signaling facilitates resolution of acute liver injury by priming macrophage polarization

扫码查看
Due to their broad functional plasticity,myeloid cells contribute to both liver injury and recovery during acetaminophen overdose-induced acute liver injury(APAP-ALI).A comprehensive understanding of cellular diversity and intercellular crosstalk is essential to elucidate the mechanisms and to develop therapeutic strategies for APAP-ALI treatment.Here,we identified the function of IFN-I in the myeloid compartment during APAP-ALI.Utilizing single-cell RNA sequencing,we characterized the cellular atlas and dynamic progression of liver CD11b+cells post APAP-ALI in WT and STAT2 T403A mice,which was further validated by immunofluorescence staining,bulk RNA-seq,and functional experiments in vitro and in vivo.We identified IFN-I-dependent transcriptional programs in a three-way communication pathway that involved IFN-I synthesis in intermediate restorative macrophages,leading to CSF-1 production in aging neutrophils that ultimately enabled Trem2+ restorative macrophage maturation,contributing to efficient liver repair.Overall,we uncovered the heterogeneity of hepatic myeloid cells in APAP-ALI at single-cell resolution and the therapeutic potential of IFN-I in the treatment of APAP-ALI.

APAP-ALIIFN-IMacrophage polarizationscRNA-seqSTAT2 T403 phosphorylationCSF1+ neutrophil

Qiaoling Song、Shyamasree Datta、Xue Liang、Xiaohan Xu、Paul Pavicic、Xiaonan Zhang、Yuanyuan Zhao、Shan Liu、Jun Zhao、Yuting Xu、Jing Xu、Lihong Wu、Zhihua Wu、Minghui Zhang、Zhan Zhao、Chunhua Lin、Yuxin Wang、Peng Han、Peng Jiang、Yating Qin、Wei Li、Yingying Zhang、Yonglun Luo、Ganes Sen、George R.Stark、Chenyang Zhao、Thomas Hamilton、Jinbo Yang

展开 >

Key Laboratory of Marine Drugs,Ministry of Education,School of Medicine and Pharmacy,Ocean University of China,Qingdao,China

Department of Inflammation and Immunity,Lerner Research Institute,Cleveland Clinic Foundation,Cleveland,OH,USA

Lars Bolund Institute of Regenerative Medicine,Qingdao-Europe Advanced Institute for Life Sciences,BGI-Qingdao,BGI-Shenzhen,Shenzhen,China

Innovation Center of Marine Drug Screening&Evaluation,Qingdao National Laboratory for Marine Science and Technology,Qingdao,China

Department of Radiation,Affiliated Hospital of Qingdao University,Qingdao,China

Department of Urology,Yantai Yuhuangding Hospital,Yantai,China

Department of Cancer Biology,Lerner Research Institute,Cleveland Clinic Foundation,Cleveland,OH,USA

展开 >

Key R&D Program of Shandong ProvinceShandong Provincial Key Laboratory Platform ProjectMajor Program of National Natural Science Foundation of China

2020CXGC0105032021ZDSYS1181991525

2023

中国免疫学杂志(英文版)
中国免疫学会

中国免疫学杂志(英文版)

CSTPCDCSCDSCI
影响因子:0.731
ISSN:1672-7681
年,卷(期):2023.20(2)
  • 53